Who
Shweta Maniar
Director
Company insider
Files Form 4 as: Director, RxSight; Director, Orthofix Medical; Director, SeaSpine Holdings.
In numbers
- Trades disclosed
- 25
- Buys
- 0
- Sells
- 7
- Bought
- $0
- Sold
- $1.1M
- Companies
- 3
- Companies where not an officer
- 3
- First trade
- 1 Apr 2021
- Last trade
- 17 Jun 2026
- Last filed
- 18 Jun 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 17 Jun 2026filed 18 Jun 2026 | RXST RxSightMedical Devices | SEC FORM 4 Code A | —37,037 | filing |
| 17 Jun 2026filed 18 Jun 2026 | RXST RxSightMedical Devices | SEC FORM 4 Code A | —37,037 | filing |
| 10 Jun 2026filed 12 Jun 2026 | OFIX Orthofix MedicalMedical Devices | SEC FORM 4 Code A | —14,965 at $0.00 | filing |
| 10 Jun 2026filed 12 Jun 2026 | OFIX Orthofix MedicalMedical Devices | SEC FORM 4 Code A | —14,965 at $0.00 | filing |
| 18 Jun 2025filed 23 Jun 2025 | OFIX Orthofix MedicalMedical Devices | SEC FORM 4 Code A | —18,841 at $0.00 | filing |
| 3 Jun 2025filed 4 Jun 2025 | RXST RxSightMedical Devices | SEC FORM 4 Code A | —10,752 | filing |
| 22 Jan 2025filed 27 Jan 2025 | RXST RxSightMedical Devices | SEC FORM 4 Sold | $109K3,519 at $30.87 | filing |
| 26 Nov 2024filed 26 Nov 2024 | RXST RxSightMedical Devices | SEC FORM 4 Sold | $174K3,782 at $45.88 | filing |
| 18 Jun 2024filed 20 Jun 2024 | OFIX Orthofix MedicalMedical Devices | SEC FORM 4 Code A | $195K15,152 at $12.87 | filing |
| 6 Jun 2024filed 10 Jun 2024 | RXST RxSightMedical Devices | SEC FORM 4 Code A | —2,554 | filing |
| 18 Jan 2024filed 19 Jan 2024 | RXST RxSightMedical Devices | SEC FORM 4 Sold | $161K3,520 at $45.69 | filing |
| 18 Jan 2024filed 19 Jan 2024 | RXST RxSightMedical Devices | SEC FORM 4 Sold | $132K2,879 at $45.76 | filing |
| 8 Jan 2024filed 9 Jan 2024 | RXST RxSightMedical Devices | SEC FORM 4 Sold | $289K6,418 at $45.00 | filing |
| 29 Aug 2023filed 29 Aug 2023 | RXST RxSightMedical Devices | SEC FORM 4 Sold | $120K4,292 at $28.06 | filing |
| 1 Jun 2023filed 5 Jun 2023 | RXST RxSightMedical Devices | SEC FORM 4 Code A | —5,731 at $0.00 | filing |
| 10 Mar 2023filed 5 Apr 2023 | OFIX Orthofix MedicalMedical Devices | SEC FORM 4 Sold | $76K4,262 at $17.75 | filing |
| 5 Jan 2023filed 9 Feb 2023 | OFIX Orthofix MedicalMedical Devices | SEC FORM 4 Code A | —14,354 at $0.00 | filing |
| 5 Jan 2023filed 9 Jan 2023 | OFIX Orthofix MedicalMedical Devices | SEC FORM 4 Code A | —14,052 at $0.00 | filing |
| 5 Jan 2023filed 9 Jan 2023 | SeaSpine Holdings | SEC FORM 4 Code D | —23,993 | filing |
| 29 Dec 2022filed 30 Dec 2022 | SeaSpine Holdings | SEC FORM 4 Sold | $30K3,786 at $8.00 | filing |
News
Shweta Maniarbioxconomy.com · 16 Oct 2026Shweta Maniar is the Global Director of Life Sciences Solutionsbioxconomy.com · 16 Oct 2026RxSight Appoints Eye Care Industry Leaders to Drive Commercial TransformationRXST · manilatimes.net · 19 Oct 2026RxSight (NASDAQ:RXST) vs. Coloplast A/S (OTCMKTS:CLPBY) Head to Head AnalysisRXST · tickerreport.com · 14 Oct 2026Financial Survey: RxSight (NASDAQ:RXST) versus Envoy Medical (NASDAQ:COCH)RXST · themarketsdaily.com · 11 Oct 2026SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Shareholders of an Investigation Concerning Possible Breaches of Fiduciary Duties by Certain Officers and Directors of Orthofix Medical Inc. (NASDAQ: OFIX)OFIX · prnewswire.com · 9 Oct 2026
2 headlines in the last 90 days name Shweta Maniar; 4 articles from the last 14 days about the 2 companies they traded most, at most three about any one of them.